regn5458,elranatamab,teclistamab
regeneron pharmaceuticals,janssen,pfizer,genmab
['elranatamab', 'regn5458', 'teclistamab']
bispecific antibodies are showing unprecedented single agent activity in relapsed/refractory mm. there are several phase i trials in this setting, let s see at the data shared at #asco22 and #eha2022 with teclistamab , elranatamab and regn5458 targeting bcma and 
Chief of Myeloma @MSKCancerCenter | Chair @ALLIANCE_org #mmsm Comm. |Physician ? Provider| @ASH_hematology @ASTCT @ASCO |married to @ZainabShd | #BMTsm #CARTsm